Aramark 8-K, filed Feb 4, 2026
Aramark (ARMK)
8-K
2026-02-04
For: 2026-02-03
View Original
Added on
April 11, 2026
About this 8-K
Aramark filed this 8-K on February 4, 2026, reporting on events of February 3, 2026.
Items reported
- Item 5.07: Shareholder vote results
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM 8-K
____________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
| Date of Report (Date of earliest event reported): | |||||||||||
____________________________ | |||||||||||
(Exact name of Registrant as Specified in its Charter) ____________________________ | |||||||||||
| (State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | |||||||||
| (Address of Principal Executive Offices) | (Zip Code) | ||||||||||
(Registrant's Telephone Number, Including Area Code) | |||||||||||
N/A (Former name or former address, if changed since last report.) | |||||||||||
__________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol(s) | Name of Each Exchange on which Registered | |||||||||
par value $0.01 per share | |||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
Aramark (the "Company") held its 2026 Annual Meeting of Shareholders on February 3, 2026. At the meeting, shareholders voted on the matters disclosed in the Company’s Proxy Statement filed by the Company with the Securities and Exchange Commission on December 22, 2025 (the "Proxy Statement"). Set forth below are the final voting results with respect to each matter voted upon by the Company’s shareholders:
1.Election of each of the following 11 director nominees to the Company’s Board of Directors to serve until the Company’s 2027 Annual Meeting, or until his or her respective successor has been duly elected and qualified:
| Nominees for Director | For | Against | Abstentions | Broker Non-Votes | ||||||||||||||||||||||
| Susan M. Cameron | 241,971,340 | 2,091,920 | 168,114 | 6,179,059 | ||||||||||||||||||||||
| Greg Creed | 243,955,494 | 164,310 | 111,570 | 6,179,059 | ||||||||||||||||||||||
| Brian M. DelGhiaccio | 243,652,437 | 467,069 | 111,868 | 6,179,059 | ||||||||||||||||||||||
| Richard W. Dreiling | 243,586,935 | 532,907 | 111,532 | 6,179,059 | ||||||||||||||||||||||
| Bridgette P. Heller | 243,640,987 | 422,284 | 168,103 | 6,179,059 | ||||||||||||||||||||||
| Kenneth M. Keverian | 244,008,653 | 111,017 | 111,704 | 6,179,059 | ||||||||||||||||||||||
| Karen M. King | 244,004,005 | 117,566 | 109,803 | 6,179,059 | ||||||||||||||||||||||
| Patricia E. Lopez | 243,951,938 | 169,814 | 109,622 | 6,179,059 | ||||||||||||||||||||||
| Stephen I. Sadove | 237,679,111 | 6,440,358 | 111,905 | 6,179,059 | ||||||||||||||||||||||
| Kevin G. Wills | 244,008,942 | 110,032 | 112,400 | 6,179,059 | ||||||||||||||||||||||
| John J. Zillmer | 240,763,043 | 3,245,028 | 223,303 | 6,179,059 | ||||||||||||||||||||||
2.Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending October 2, 2026:
| For | Against | Abstentions | Broker Non-Votes | |||||||||||||||||
| 249,670,984 | 630,629 | 108,820 | 0 | |||||||||||||||||
3.Approval, on a non-binding, advisory basis, of the compensation of the Company’s named executive officers as disclosed in the Proxy Statement:
| For | Against | Abstentions | Broker Non-Votes | |||||||||||||||||
| 239,320,000 | 4,566,394 | 344,980 | 6,179,059 | |||||||||||||||||
Item 9.01. Financial Statements and Exhibits
| (d) Exhibits | ||||||||
Exhibit No. | Description | |||||||
| 104 | Cover Page Interactive Date File (embedded within the Inline XRBL document) | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Aramark | ||||||||||||||
| Date: | February 4, 2026 | By: | /s/ James J. Tarangelo | |||||||||||
| Name: | James J. Tarangelo | |||||||||||||
| Title: | Executive Vice President and | |||||||||||||
| Chief Financial Officer | ||||||||||||||